Form 4: GE HealthCare Director Kevin Lobo Receives Stock Award

Director Kevin Lobo acquired 3,586 restricted stock units in GE HealthCare Technologies Inc. as part of a standard equity grant.

Summary

• Director Kevin Lobo was granted 3,586 restricted stock units (RSUs) on May 7, 2026.
• Each RSU represents the right to receive one share of GE HealthCare common stock.
• The units vest on the earlier of the next annual meeting of stockholders or May 7, 2027.
• Following this transaction, the director's total beneficial ownership is 4,363 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified; this is a routine compensatory equity grant.

Risks

• None identified; this is a standard regulatory disclosure of director compensation.

Future Outlook

The restricted stock units are scheduled to vest in one year, subject to the director's continued service or the date of the next annual meeting.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practices designed to incentivize long-term oversight and alignment with shareholder value in the medical technology sector.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with standard compensation practices for S&P 500 and large-cap healthcare companies.
• The vesting schedule of one year is typical for annual director equity retainers.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensatory grant.

Next Steps

• Vesting of the 3,586 restricted stock units on or before May 7, 2027.

Key Dates

Keywords

GE HealthCare, GEHC, Form 4, Insider Trading, Director Compensation, Restricted Stock Units